1. 1ODouble PIK3CA mutations in cis enhance PI3Kα oncogene activation and sensitivity to PI3Kα inhibitors in breast cancer. (13th May 2019) Authors: Vasan, N; Razavi, P; Johnson, J L; Shao, H; Reznik, E; Smith, M L; Sebra, R; Cantley, L C; Scaltriti, M; Baselga, J Journal: Annals of oncology Issue: Volume 30(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Direct measurement of the 3d2D3/2 to 3d2D5/2 lifetime ratio in a single trapped 40Ca+. (22nd January 2018) Authors: Shao, H; Huang, Y; Guan, H; Gao, K Journal: Journal of physics Issue: Volume 51:Number 4(2018:Feb. 15) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Laser ablation and two-step photo-ionization for the generation of 40Ca+. (19th September 2018) Authors: Shao, H; Wang, M; Zeng, M; Guan, H; Gao, K Journal: Journal of physics communications Issue: Volume 2:Number 9(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. LBA26Updated safety and clinical activity results from a phase Ib study of atezolizumab + bevacizumab in hepatocellular carcinoma (HCC). (23rd October 2018) Authors: Pishvaian, M J; Lee, M S; Ryoo, B-Y; Stein, S; Lee, K-H; Verret, W; Spahn, J; Shao, H; Liu, B; Iizuka, K; Hsu, C-H Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P107: A PHASE 2/3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF MITAPIVAT IN PATIENTS WITH SICKLE CELL DISEASE. (31st January 2022) Authors: Howard, J; Kuo, K; Oluyadi, A; Shao, H; Morris, S; Zaidi, A; Van Beers, E; Thein, S Journal: HemaSphere Issue: Volume 6(2022)Supplement 1 Page Start: 20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗